Annual Drug Patent Expirations for DICLEGIS
Diclegis is a drug marketed by Duchesnay and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for DICLEGIS.
This drug has forty-nine patent family members in thirty-six countries.
The generic ingredient in DICLEGIS is doxylamine succinate; pyridoxine hydrochloride. Three suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
